Medical, Marketing and Media | MM&M | Home

The 2019 MM&M Awards: The shortlist

Find out who made award-winning work this year.
Condé Nast industries lead draws on health heritage

Jennifer Mormile is chief industries officer and SVP of the lifestyle division at Condé Nast.
“So, how was your year?” Iskowitz and Dobrow on the making of the Agency 100

Editors Marc Iskowitz and Larry Dobrow unpack MM&M’s Agency 100 issue in this edited transcript of their conversation for The MM&M Podcast.
Are you making as much money as your peers?

The 2019 MM&M Career & Salary Survey is open.
2019 MM&M Agency 100

Breaking down the North American healthcare marketing sector.

LATEST NEWS

Havas ECS will focus on science-based education and communications about cannabinoids.

Oklahoma prosecutors compare J&J to drug ‘kingpin’; Biden unveils healthcare plan; Gilead increases stake in Galapagos.

Staying wholly owned by WPP would have limited ambitions, Kantar CEO says.

After its setback in the Oklahoma opioid trial, J&J should compromise rather than face judgment.

The company’s failed bid to have the Oklahoma opioid case tossed was followed this week by a reported criminal probe into its talcum baby powder.

Feds to pursue criminal investigation into J&J; 23andMe wants access to medical records alongside DNA; Another Alzheimer’s trial fails.

The coalition is made up of 12 eye-health pharma and biotech companies.

Researchers looked at the effectiveness of court-ordered anti-smoking campaigns paid for by the tobacco industry.

The sale valued Kantar at $4 billion.

CVS to expand health-focused stores; Reckitt Benckiser to pay $1.4 billion to end opioid probes; House committee discusses marijuana legalization.